Patents Examined by Konata M. George
  • Therapeutic body lotion containing alkali metal hypohalite
    Patent number: 6589568
    Abstract: A topically applied composition capable of treating subcutaneous tissue comprising an alkali metal hypohalite (AMH) (preferably, sodium hypochlorite) and a conventional skin lotion. The skin lotion serves both as a carrier and as an antidrying agent for the AMH. The AMH penetrates through the skin's pores and lymph nodes into the subcutaneous tissue. The AMH stimulates the immune system to alleviate, and sometimes cure, inflammation, aches, pains, and other symptoms caused by microbial (e.g., viral, bacterial, fungal and parasitic) infection, arthritis, hemorrhoids, allergies, etc.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: July 8, 2003
    Assignee: Nurad, Inc.
    Inventors: Jurdon Wayne Camper, Marilyn A. Delorme, John E. Festvog
  • Nasally administrable compositions
    Patent number: 6589559
    Abstract: A nasally administrable composition of a physiologically active substance, wherein an effective amount of said physiologically active substance is dispersed homogeneously in and adsorbed homogeneously onto a fine powdery form of a cereal, thereby enhancing the absorption of the physiologically active substance into a body via the nasal route. Examples of the cereal are rice, wheat, soybean, corn, foxtail, millet, buckwheat and the like, especially rice, and the physiologically active substance is a physiologically active peptide.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: July 8, 2003
    Assignee: DOTT Research Laboratory
    Inventor: Akira Yanagawa
  • Method of using optically-activated particles in cosmetic preparations
    Patent number: 6586013
    Abstract: Optically-activated particles for use in cosmetic preparations. The optically-activated particles include a plurality of substrate particles selected from the group consisting of nylons, acrylics, polyesters, other plastic polymers, natural materials, regenerated cellulose, metals and minerals; an optical brightener chemically bonded to each of the plurality of substrate particles to form integral units in the form of optically-activated particles for diffusing light to reduce the visual perception of skin imperfections, including cellulite, shadows, skin discolorations, and wrinkles; and each of the optically-activated particles are encapsulated with a UV transparent coating to increase the diffusion light to further reduce the visual perception of the skin imperfections.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: July 1, 2003
    Assignee: Lipo Chemicals, Inc.
    Inventor: Bruce H. Victor
  • Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
    Patent number: 6576230
    Abstract: A synergistic biocidal composition comprising a mixture of 2-propenal polymer (APC) and 5-chloro-2-methyl-4-isothiazoline-3-one (CIT) and 2-methyl-4-isothiazoline-3-one (MIT).
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: June 10, 2003
    Assignee: ISP Investments Inc.
    Inventors: Liu Xianbin, Karen Winkowski
  • Cosmetic compositions comprising at least one catonic polymer and at least one nonionic associative polymer
    Patent number: 6572869
    Abstract: A cosmetic composition comprising, in a cosmetically acceptable medium, at least one cationic polymer containing at least one acrylamide unit or acrylamide derivative, and at least one nonionic associative polymer containing at least one fatty chain.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: June 3, 2003
    Assignee: L'Oreal S.A.
    Inventors: Véronique Douin, Juan Lopez, Fréderic Cervantes
  • Method for providing dibenzoylmethane derivatives with light stability
    Patent number: 6569409
    Abstract: The invention concerns novel light-stable filtering cosmetic compositions for topically protecting the skin and/or the hair against ultraviolet radiation, in particular solar radiation, comprising in a cosmetically acceptable support, at least a dibenzoylmethane derivative and at least an oily phase, and an efficient amount of at least a thickening copolymer including at least a hydrophobic unit in sufficient amount for it to be partially or completely soluble in the oily phase and at least a hydrophilic unit in sufficient amount for thickening the oily phase as stabilizing agent for the filter. The invention also concerns the corresponding method for providing dibenzoylmethane with light stability and the use of the compositions for skin and hair protection against the effects of ultraviolet radiation.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: May 27, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Isabelle Hansenne, Martin Josso
  • Nanocapsules based on poly(alkylene adipate), process for their preparation and cosmetic or dermatological compositions containing them
    Patent number: 6565886
    Abstract: The present invention relates to nanocapsules consisting of a lipid centre forming or containing a lipophilic active principle, and of a water-insoluble continuous envelope comprising at least one polyester of poly(alkylene adipate) type as well as to cosmetic and/or dermatological compositions containing the said nanocapsules based on poly(alkylene adipate).
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: May 20, 2003
    Assignee: L'Oreal
    Inventors: Jean-Thierry Simonnet, Pascal Richart, Bruno Biatry
  • Targeted hysteresis hyperthermia as a method for treating diseased tissue
    Patent number: 6565887
    Abstract: A method for site specific treatment of diseased tissue in a patient, comprising the steps of: (i) selecting at least a magnetic material which has a magnetic heating efficiency of at least about 4.5×10−8 J.m./A.g, when magnetic field conditions are equal to or less than about 7.5×107 A/s; (ii) delivering the magnetic material to diseased tissue in a patient; and (iii) exposing the magnetic material in the patient to a linear alternating magnetic field with a frequency of greater than about 10 kHz and a field strength such that the product of field strength, frequency and the radius of the exposed region is less than about 7.5×107 A/s to generate hysteresis heat in the diseased tissue.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: May 20, 2003
    Assignee: Sirtex Medical Limited
    Inventors: Bruce Nathaniel Gray, Stephen Keith Jones
  • Antiviral drugs containing heteropolyanions
    Patent number: 6565890
    Abstract: A compound for use especially as an antiviral drug, mainly containing salts of heteropolyanions consisting of a tungstoantimonate (III) vanadium-mixed metal oxide or related salts represented by formula [(XW9O33)2V3O3]P−, where p is a positive number between 9 and 12 and X is Sb, P. As or Bi and especially Sb. An antiviral drug having a broad spectrum of antiviral activity, high potent efficacy and low toxicity is provided.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: May 20, 2003
    Assignee: Polytronics, Ltd.
    Inventors: Shiro Shigeta, Toshihiro Yamase
  • Nontoxic vernix compositions and method of producing
    Patent number: 6562358
    Abstract: A protectant composition comprising vernix for a skin curative and skin protectant effect and a method of using the composition. A natural or synthetic vernix is dispersed in an effect amount and is applied to a surface. The method may be used to repel a naturally occurring agent such as water, or a synthetic agent to which exposure may occur, for example, in an occupational setting.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: May 13, 2003
    Assignee: Children's Hospital Medical Center
    Inventors: Steven B. Hoath, Martha O. Visscher
  • Sustained release ranolazine formulations
    Patent number: 6562826
    Abstract: A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 850 and 4000 ng base/mL.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: May 13, 2003
    Assignee: CV Therapeutics, Inc.
    Inventor: Andrew A. Wolff
  • Container for an inhalation anesthetic
    Patent number: 6558679
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: May 6, 2003
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Cosmetic products comprising cream of tarter and sodium bicarbonate
    Patent number: 6558681
    Abstract: A cosmetic product and the like, including a deodorant, comprising a dicarboxylic acid and sodium bicarbonate preferably dihydroxybutanedioic acid and sodium bicarbonate and most preferably comprising cream of tarter and sodium bicarbonate. A mixture of sodium bicarbonate, cream of tarter and water forms a paste which hardens into a solid over a period of a few hours. The mixture provides a solid material which is highly stable. It does not dissolve quickly and does not effervesce, but instead remains essentially stable and retains it's solid form.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: May 6, 2003
    Assignee: Lush Limited
    Inventors: Helen Ambrosen, Mark Constantine, Margaret Constantine
  • Cosmetic product systems comprising a transfer resistant, flexible film-forming cosmetic product and an oil-containing composition
    Patent number: 6555097
    Abstract: Cosmetic product systems comprise a transfer resistant, flexible film forming cosmetic product having a solubility parameter on the Hildebrand scale of less than or equal to 8.5 (calories/cm3)½, and a second composition comprising an oil having a C log P value greater than or equal to 13. The oil is selected from the group consisting of polyol fatty acid polyesters, triglycerides, glycerin/diethylene glycol/adipate cross polymers and mixtures thereof.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: April 29, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Thomas Elliot Rabe, Lee Ellen Drechsler, Edward Dewey Smith, III, Terutomo Dohmae, Christina M. Hines
  • Biomedical moldings
    Patent number: 6555103
    Abstract: The present invention is concerned with a biomedical molding comprising a non-biodegradable biocompatible organic polymer comprising attached to its surface radicals of formula wherein the variables are as defined in the claims. The biomedical moldings of the invention are radiation sensitive and may be used, for example, as intraocular lens in ophthalmic surgery.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: April 29, 2003
    Assignee: Novartis AG
    Inventors: Jörg Leukel, Peter Chabrecek, Dieter Lohmann
  • Antibiofouling method and apparatus for optical sensors
    Patent number: 6551583
    Abstract: An antibiofouling material, a method for making said antibiofouling material, a sensor apparatus employing said antibiofouling material, and a method of making said sensor apparatus. The disclosed antibiofouling material includes one or more biocides and one or more charge transfer compounds are embedded within a copolymer host matrix. Biocides used in the present invention may include, but are not limited to, Halobenzonitriles, Azoles, diuron; and simazine. Among its uses, the antibiofouling material of the present invention can be used in a sensor apparatus. In a preferred embodiment, one or more surfaces of said sensor apparatus are coated with an antibiofouling material comprised of one or more biocides, one or more charge transfer compounds, and a copolymer host matrix.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: April 22, 2003
    Assignee: Airak, Inc,
    Inventors: Paul G. Duncan, Sean Michael Christian, David M. Orcutt
  • Hair styling composition comprising adhesive particles
    Patent number: 6548051
    Abstract: Hair styling compositions that comprise at least one adhesive particle, optionally in a cosmetically acceptable carrier, wherein said at least one adhesive particle comprises at least one substrate and an at least partial coating, wherein said at least partial coating comprises at least one adhesive, wherein the at least one substrate and the at least partial coating are not the same, and wherein the at least one adhesive particle has a mean length greater than 1 micron. The present invention also relates to methods of providing a holding and/or reshapable effect to the hair using the compositions of the invention and methods of manufacturing of said compositions.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: April 15, 2003
    Assignee: L′Oreal
    Inventors: Nathalie Garnier, Henri Samain
  • Make-up or care composition containing a crosslinked polyorganosiloxane containing an oxyalkylenated group
    Patent number: 6548050
    Abstract: The present invention provides a dermatologic or cosmetic composition, including a liquid fatty phase, and, as surfactant and thickener for the liquid fatty phase, particles of a crosslinked elastomeric solid polyorganosiloxane containing at least one oxyalkylenated group. Another embodiment of the invention relates to methods of using particles of a crosslinked elastomeric solid polyorganosiloxane containing at least one oxyethylenated group. The present invention is especially suitable for a care or make-up composition for human skin and lips, and overcomes the various drawbacks in known compositions.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: April 15, 2003
    Assignee: L'Oreal
    Inventor: Isabelle Bara
  • Composition and method for producing lubricating, germicide foam
    Patent number: 6544539
    Abstract: A method for producing a foam surfactant, and foam product suitable for a combined bovine teat dip and teat wash comprises air pressurization of a surfactant solution containing a germicide, disinfectant, biocide, etc., passing the air-surfactant mixture through a flow or line mixer to a foam holding cup adjacent the teat area and expanding the mixture to atmospheric in the holding cup to produce an adherent surfactant foam product with reduced run-off, which both protects and reduces infection of the teat, particularly at the teat canal and surrounding udder area.
    Type: Grant
    Filed: February 16, 2002
    Date of Patent: April 8, 2003
    Assignee: Devtech Marketing, Inc.
    Inventor: David J. Ricketts
  • Regulated release preparations
    Patent number: 6544554
    Abstract: Controlled-release formulation having such a portion that the core and a drug release layer each of which has been formulated to effect rapid or gradual release of at least one drug the release of which is to be controlled is covered either partly or entirely with a release control layer that is produced by adding pharmaceutically acceptable additives to at least one base selected from among fumaric acid, DL-tryptophan and L-tyrosine and which is substantially free from the drugs the release of which is to be controlled.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: April 8, 2003
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Hiroyuki Maeda, Yutaka Ogawa, Yoshimitsu Iida